Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to ...
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line ...
If we can say “COVID is still here,” then what of tuberculosis (TB), which has been around since time immemorial and has ...
At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a ...
10d
Study by HaystackAnalytics & Dr. D.Y. Patil Medical College reveals high prevalence of pre-XDR-TB in MDR-TB cases in India.
The findings highlighted resistance not only to rifampicin, a drug used to manage and treat diverse mycobacterial infections, ...
Delamanid approval for under-5 children in india revolutionizes pediatric tb treatment, eliminating painful injectables ...
A new report from WHO and the ECDC says that 7000 estimated excess tuberculosis deaths in the WHO European region in 2020–22 ...
Its own bill for landmark trials of a four-drug combination treatment for drug-resistant tuberculosis came to €34m (£29m). Current estimates for research and development of new medicines range ...
Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from ...
The study is based on real-world data on the TB drug-resistance profile by whole genome sequencing (WGS) of 600 clinical ...
Some immune-enhancing therapies already exist, and their use could be investigated while other immunomodulatory drugs specific to different sub-groups of TB disease are being developed Experts are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback